John Spencer
Papers
3
Total Citations
16
H-Index
3
About
John Spencer is a leading figure in fragment-based drug discovery, whose work addresses one of the field’s most persistent bottlenecks: the efficient progression of weak fragment hits into potent lead compounds. His research centers on integrating high-throughput crystallography with innovative synthetic chemistry to accelerate hit-to-lead development. Spencer’s major contribution is the development of Binding-Site Purification of Actives (B-SPA), a methodology that combines multi-step array synthesis with high-throughput crystallography to enable the rapid, large-scale exploration of fragment growth. This approach, detailed in his most-cited paper (2025, 9 citations), bypasses traditional purification challenges by leveraging the binding site itself to isolate active compounds from crude reaction mixtures. His earlier work (2023, 4 citations) demonstrated the power of low-cost robotics and crude array deconvolution for rapid structural data collection, laying the groundwork for B-SPA. With over 16 citations across his key publications, Spencer’s impact is already evident in reshaping how researchers approach fragment progression, offering a scalable, cost-effective pathway that unlocks the dormant potential of fragment screening. His achievements promise to democratize access to advanced structural biology tools, making him a pivotal innovator in modern drug discovery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3